Study of Stapled Transanal Rectal Resection (STARR) Surgery in Refractory Constipation Associated With Obstructive Defecation Syndrome (ODS)

Ethicon Endo-Surgery75 enrolled

Overview

The primary purpose of this study is to determine how effective and how durable STARR (stapled transanal rectal resection) surgery is in relieving symptoms of intractable constipation associated with obstructive defecation syndrome (ODS).

Rectocele and rectal intussusception are frequent findings in women but are often asymptomatic apart from anatomical defects, which can be seen on vaginal examination. They can be associated, however, with refractory constipation that may be best described by the terms "Outlet Obstruction" or "Obstructive Defecation Syndrome (ODS)". ODS is characterized by a symptom complex, including the feeling of incomplete evacuation associated with the need to strain excessively and for external assistance (digital, mechanical or positional maneuvers, enemas or suppositories) to aid defecation. Abdominal or rectal pain is also a common complaint. Obstetric trauma is also recognized as a contributing factor. However, none of these symptoms/factors can be singled out to be pathognomonic for this problem. ODS has a prevalence of approximately 12% in the general population. For individuals with ODS and related intussusception/rectocele, a variety of surgical techniques including abdominal, vaginal, transanal and perineal approaches have been devised. The impact of clinical studies to evaluate these techniques has been limited by variability of results and lack of comparators. Recently, a new surgical approach was developed by an Italian surgeon, A. Longo, and has been evaluated in several European centers. These early studies and observations indicate that this new procedure may in fact provide significantly better symptom resolution in ODS patients than other available treatments, and warrants further study. The procedure is referred to as "Stapled Transanal Rectal Resection (STARR)" and this study will assess its effectiveness in a United States population.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Obstructive Defecation Syndrome Chronic Constipation Rectocele Intussusception

Interventions

Stapled Transanal Resection (STARR) with Transtar (PROXIMATE®) 33 mm Circular StaplerPROCEDURE

Eligibility

Sex: FEMALEMin age: 21 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Able to comprehend, understand, and speak the English language * Able to comprehend, follow, and sign an informed consent document (ICD) * Able to tolerate general or spinal anesthetic * Often experience excessive straining, sense of incomplete evacuation, and/or prolonged time for complete evacuation when attempting a bowel movement * Have experienced ODS symptoms for at least 12 months prior to enrollment * Have a minimum ODS score of 10 * Have rectocele and/or rectal intussusception confirmed by defecography * Screened for colorectal neoplasia within 7 years of the screening visit (e.g., colonoscopy or barium enema) * Have an American Society of Anesthesiologists (ASA) score of no more than 3 * Willing to comply with evaluation and management schedule through 5-year follow-up Exclusion Criteria: * Fecal incontinence to solid stool * Full-thickness prolapse * Perineal infection * Recto-vaginal fistula * Enterocele (at rest) * Any complex pelvic floor prolapse requiring a combined surgical approach * Prior sigmoid or anterior resection or prior rectal anastomosis * Presence of foreign material adjacent to the rectum (e.g., vaginal mesh) * Grade IV hemorrhoids * Pregnancy * Chronic narcotic use * Evidence of colorectal neoplasia, carcinoma, or inflammatory bowel disease * Physical or psychological condition which would impair study participation * Unable or unwilling to attend follow-up visits and examinations * Surgical procedure required concurrently with STARR * Prior pelvic radiotherapy * Failure to identify any anatomical or physiological abnormality in the evaluation * Significant rectal fibrosis * Anal stenosis precluding insertion of the stapling device * Participation in any other investigational device or drug study 30 days prior to enrollment * Presence or history of hepatitis B, hepatitis C, and/or HIV positive test

Locations (7)

Colon and Rectal Clinic of Orlando

Orlando, Florida, United States

Lahey Clinic

Burlington, Massachusetts, United States

Colon & Rectal Surgery Associates Ltd.

Minneapolis, Minnesota, United States

University Hospitals of Cleveland

Cleveland, Ohio, United States

Outcomes

Primary Outcomes

Percentage of Change (Reduction) in Total ODS Symptom Composite Score From Baseline to One Year Post Procedure

The primary endpoint used to assess effectiveness of STARR for treatment of ODS was the percentage of change in total ODS symptom composite score (0=worst, 24=best) 1 year after completion of the procedure.

Time frame: one year from Baseline

Secondary Outcomes

Percentage of Change in ODS Symptom Composite Score From Baseline at 1 Month Post Procedure

Percentage of change in Obstructive Defecation Syndrome (ODS) symptom composite score from baseline at 1 month post procedure. This score is based on a series of questions designed to understand the extent ODS effects an individual's daily lifestyle (0 is worst score, 24 is best score). Sizing consistent with primary outcome; analysis was per-protocol.

Time frame: Baseline, 1 month post procedure

Maximum Change in Subject-reported Assessment of Symptom Severity and Frequency (PAC SYM).

Assessed as patient-reported assessment of symptom severity and frequency (PAC-SYM)associated with constipation. Patient response options are absent, mild, moderate, severe, and very severe.12 questions relate to severity, 8 questions relate to frequency of symptoms. The lower the score, the less severe the symptoms. Sizing consistent with primary outcome; analysis was per-protocol.

Time frame: Baseline, 6 months

Percentage of Change in ODS Symptom Composite Score From Baseline at 6 Months (0 is Worst Score, 24 is Best Score)

Time frame: Baseline, 6 months post procedure

PAC QOL Patient Assessment of Constipation (Overall)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.